Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022
Sara Kim, Jessie R. Chung, H. Keipp Talbot, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 16, Iss. 6, pp. 975-985
Open Access | Times Cited: 18

Showing 18 citing articles:

Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season
Ashley M Price, Brendan Flannery, H. Keipp Talbot, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 8, pp. 1358-1363
Open Access | Times Cited: 37
A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
Hassen Mohammed, Dan Duy Pham-Tran, Zi Yi Michelle Yeoh, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 224-224
Open Access | Times Cited: 34
Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies
Shangchen Song, Zachary J. Madewell, Ming‐Jin Liu, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 29
Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network
Sara Y. Tartof, Fagen Xie, Ruchi Yadav, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 5
Open Access | Times Cited: 16
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Charlotte Lanièce Delaunay, Iván Martínez‐Baz, Noémie Sève, et al.
Eurosurveillance (2024) Vol. 29, Iss. 13
Open Access | Times Cited: 6
Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022
Kelsey M. Sumner, Ruchi Yadav, Emma K. Noble, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 1, pp. 45-54
Open Access | Times Cited: 3
Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network
Sara Y. Tartof, Fagen Xie, Ruchi Yadav, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions
Ruth Link‐Gelles, Amadea Britton, Katherine E. Fleming-Dutra
Vaccine (2023) Vol. 42, pp. 125492-125492
Open Access | Times Cited: 5
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates
Patricia Pérez, Guillermo Albericio, David Astorgano, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
SARS‐CoV‐2 Omicron BA.5: Riding the seventh wave in Central Canada
Toni Li, Adrian Yung, Carolyn Tran, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 16, Iss. 6, pp. 1202-1204
Open Access | Times Cited: 4
Health-related Quality of Life following Mild (COVID)-19 Illness
Mary Patricia Nowalk, Rachel Taber, Todd Bear, et al.
American Journal of Health Behavior (2024) Vol. 48, Iss. 2, pp. 56-67
Closed Access
Preparing for pandemics needs a dose of public health and a booster of “complex thought” (Errare humanum est, perseverare diabolicum)
Élisabeth Paul, Garrett Wallace Brown, David Bell, et al.
Global Policy (2024) Vol. 15, Iss. 5, pp. 969-978
Open Access
Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season
Ashley M. Price, Brendan Flannery, H. Keipp Talbot, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Effectiveness of SARS-CoV-2 Vaccines against Omicron Infection and Severe Events: A Systematic Review and Meta-Analysis of Test-Negative Design Studies
Shangchen Song, Zachary J. Madewell, Ming‐Jin Liu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021–June 2022
Kelsey M. Sumner, Ruchi Yadav, Emma K. Noble, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
The effect of SARS-CoV-2 double vaccination on the outcomes of hemodialysis patients with COVID-19: A meta-analysis
Guangyu Ao, Toni Li, Yushu Wang, et al.
Journal of Infection (2022) Vol. 86, Iss. 2, pp. e43-e45
Open Access | Times Cited: 2
Willingness to Co-receive COVID-19 and Influenza Vaccines among Outpatients
Krissy Moehling Geffel, Mary Patricia Nowalk, Theresa M. Sax, et al.
American Journal of Health Behavior (2023) Vol. 47, Iss. 4, pp. 725-736
Open Access
Page 1

Scroll to top